Polaris Group

Polaris group email format

Verified email-pattern data for Polaris Group is currently limited. You can still use the company insights and contact sections below.
Polaris Group is a biopharmaceutical company dedicated to pioneering advanced therapies, primarily focusing on metabolic-related diseases. Our lead drug candidate, Pegargiminase (ADZODI), is presently advancing through the BLA-enabling stage for MPM and clinical development for other indications. Pegargiminase is a biologic in late-stage clinical development for a wide range of cancers, including hepatocellular carcinoma, soft tissue sarcoma, glioblastoma, non-small cell lung cancer, melanoma, acute myeloid leukemia and others. Pegargiminase is designed to disrupt cancer cell metabolism, providing a novel approach to treating a wide range of cancers heavily influenced by metabolic pathways. Our mission is to revolutionize the treatment of complex diseases like cancer by concentrating on their metabolic foundations, ultimately striving to enhance patient outcomes globally. For more information, please visit https://www.polarispharma.com.
Looking for a particular Polaris Group employee's phone or email?

Polaris Group Questions

Explore related pages

Related company profiles:

Top Polaris Group Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant